Lanraplenib

CAS: 1800046-95-0

Ref. 3D-AXC04695

Produktinformation

• Name: Lanraplenib

Beschreibung

Lanraplenib is an experimental drug that has been shown to be effective in the treatment of autoimmune diseases. It is a small molecule that inhibits the activity of factor receptors and blocks the binding of cytokines and other inflammatory mediators to their receptors. Lanraplenib can be used for the treatment of chronic kidney disease, as well as systemic therapy for inflammatory diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. Lanraplenib has also been found to have a favorable safety profile in clinical trials.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 443.5 g/mol
• Formel: C₂₃H₂₅N₉O
• Reinheit: Min. 95%